42 results
424B3
SLGL
Sol-Gel Technologies Ltd
4 Apr 24
Prospectus supplement
9:05am
to, and is responsible for, all U.S. commercial activities for Twyneo and Epsolay, including promotion and distribution, and we were responsible for obtaining … provide that Galderma is responsible for all filings and communications with regulatory authorities in the U.S. until expiration of the applicable
POS AM
SLGL
Sol-Gel Technologies Ltd
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
the exclusive right to, and is responsible for, all U.S. commercial activities for Twyneo and Epsolay, including promotion and distribution, and we were … responsible for obtaining all regulatory approvals of the products in the United States, which we completed in July 2021 and April 2022, respectively. Each
424B3
b8upa0s0oq5bhp
10 Aug 23
Prospectus supplement
7:20am
6-K
EX-99.2
irevc19
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
xqssb q7hf5
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
3x28su91nhp49av
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
6-K
EX-99.1
fkrauneu169y1v
3 Oct 22
Sol-Gel Technologies Appoints Michael Glezin Vice
8:05am
424B5
pji9bjs3d 3ff4gq6
19 Apr 22
Prospectus supplement for primary offering
4:02pm
UPLOAD
lh2xjuog
8 Apr 22
Letter from SEC
12:00am
F-3
bal3e9t6hgzudfs xa
7 Apr 22
Shelf registration (foreign)
5:30pm
20-F/A
EX-12.2
madw8r 5f8bua
7 Apr 22
Annual report (foreign) (amended)
4:06pm
20-F/A
ovn7doi9iclnhx98
7 Apr 22
Annual report (foreign) (amended)
4:06pm
20-F/A
EX-12.1
qttpun h2qd
7 Apr 22
Annual report (foreign) (amended)
4:06pm